| Hans-Günter Meyer-Thompson | International
USA. Congress Poised to Schedule Xylazine, Because Otherwise the DEA Will Do It
USA. Congress Poised to Schedule Xylazine, Because Otherwise the DEA Will Do It
Three years in the making, the legislative push to place xylazine under Schedule III of the federal Controlled Substances Act is nearing the finish line.
On March 26, the Combatting Illicit Xylazine Act was advancedb y the Senate Judiciary Committee with a vote of 19-3, setting the stage for a vote before the full chamber. In a House Committee on Energy and Commerce hearing the same day, proponents warned about how dangerous it would be if Congress didn’t schedule xylazine—not because xylazine would remain unscheduled, but because the DEA would do it instead. (Flter, USA, 30.03.2026)